Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antituberculosis/karijes
Veza se sprema u međuspremnik
Stranica 1 iz 175 rezultatima
Permeability of tuberculous cavities to antituberculosis drugs.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Studies on the prognosis of cases with open negative cavity developing mainly due to therapy with primary antituberculosis drugs.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Empiric anti-tuberculosis treatment is not always a right way in patients who had have poorly controlled diabetes mellitus and presented with pulmonary cavities over upper lungs in tuberculosis endemic countries.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Target Engagement and Binding Mode of an Antituberculosis Drug to Its Bacterial Target Deciphered in Whole Living Cells by NMR.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Detailed information on hit-target interaction is very valuable for drug discovery efforts and indispensable for rational hit to lead optimization. We developed a new approach combining NMR in whole-cells in-cell NMR) and docking to characterize hit-target interaction at the atomic level. By using
Properties of peritoneal exudate lymphocytes that mediate tuberculin delayed-type hypersensitivity and anti-tuberculosis immunity. I. The effect of cytotoxic agents.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Acute peritoneal exudates were raised in rats that had been immunized by BCG, in order to draw into the peritoneal cavity sensitized immunoblasts. The peritoneal exudate cells (PEC) were harvested 24 h after exudate induction. The ability of these cells to confer tuberculin delayed-type
Prognostic factors associated with mortality before and during anti-tuberculosis treatment.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
OBJECTIVE
To identify factors associated with death before the start of anti-tuberculosis treatment, and early and late during treatment, among adult Taiwanese with culture-positive pulmonary tuberculosis (PTB).
METHODS
All adult culture-positive PTB patients in Taipei, Taiwan, were included in a
Assessment of the Efficacy of New Anti-Tuberculosis Drugs.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The pathology of tuberculosis in humans starts with an initial Ghon focus in the lungs followed by transmission of bacilli though the blood and lymph to other regions in the lungs and to other organs. While these bacilli usually lie latent without causing further disease, some 10% start foci of
Massive pulmonary tuberculosis cavity misdiagnosed as pneumothorax.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Massive pulmonary cavity is a rare and serious complication of chronic reactivation tuberculosis. A 38-year-old gentleman had a history of tuberculosis treatment noncompliance 2 years ago. His presenting symptoms were cough, fever, and left-sided pleuritic chest discomfort for 2 months. Chest
Effectiveness of anti-tuberculosis chemotherapy in patients with tuberculosis relapse compared with newly diagnosed patients.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The search for new sterilizing anti-tuberculosis drugs.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
To be of use in the control of tuberculosis, any new drug must be capable of shortening the duration of treatment by accelerating sterilizing activity, that is the rate at which Mycobacterium tuberculosis is killed in the lesions. The most difficult to kill are the extra-cellular bacilli in
Cucurbituril-resisted acylation of the anti-tuberculosis drug isoniazid via a supramolecular strategy.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
A chemical investigation reveals that the resistance to acylation of an anti-tuberculosis drug, isoniazid is a consequent result of the inclusion or exclusion of cucurbit[n]urils (n = 6 or 7). The (1)H NMR spectra analysis shows that the different interaction models of the isoniazid with the two
Roles of an anti-tuberculosis medication and surgery in patients with tuberculous otitis media.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
CONCLUSIONS
The standard treatment for tuberculous otitis media (TOM) without complications consists of anti-tuberculosis (anti-TB) medication, with which we experienced good treatment outcomes. However, surgery is required for recovery of anatomy and hearing function.
OBJECTIVE
To determine the
Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
METHODS
A reference hospital for tuberculosis (TB) and human immunodeficiency virus/acquired immune-deficiency syndrome (HIV/AIDS) with a TB control programme in Rio de Janeiro, Brazil.
OBJECTIVE
To estimate the prevalence of resistance to anti-tuberculosis drugs and to identify associated
[Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide].
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class of immunotropic agents were investigated with the use of 78 clinical isolates of Mycobacterium tuberculosis (MBT). In concentration of 60 or
Early bactericidal activity of antituberculosis agents.
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The early bactericidal activity (EBA) of an antituberculosis agent is arbitrarily defined as the fall in log(10) colony forming units (cfu) of Mycobacterium tuberculosis per ml sputum per day during the first 2 days of treatment. Determining the EBA is an important preliminary step in the clinical
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
